Weight Loss and Changes in Cardiovascular Risk Markers With a Low Glycemic Diet Compared With a Standard Diet
1 other identifier
interventional
200
1 country
1
Brief Summary
Overweight and obesity is increasing in most countries, including Norway, and the optimal diet for reducing weight is under discussion. The present study in overweight and moderate obese individuals compares a low glycemic load diet with a standard low-fat diet (as recommended from the National Nutrition Council) in an open, randomized trial over 12 months, with changes in weight loss and changes in cardiovascular risk markers as endpoints.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Apr 2004
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 30, 2005
CompletedFirst Posted
Study publicly available on registry
October 3, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2006
CompletedJuly 1, 2011
February 1, 2004
2.2 years
September 30, 2005
June 30, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary objective will be to compare the effects of the two different diet recommendations with respect to the one-year change in body weight.
Secondary Outcomes (9)
Compare the consequences of the two strategies with respect to 3, 6, and 12 months development of the variables; glucose/insulin,
insulin sensitivity index,
number of metabolic syndrome factors,
high sensitive C-reactive protein,
lipids and lipoprotein B and
- +4 more secondary outcomes
Interventions
Eligibility Criteria
You may qualify if:
- Men or women age 30-65,
- BMI in the range 28-35 kg/m2 for women and 28-40kg/m2 for men.
- At least one of the following components of the metabolic syndrome; fasting triglycerides \> 1,7, fasting glucose 6,0-6,9, HDL-cholesterol \<1,03 (males) or \<1,29 (females), Blood pressure \>130/85 (with or without treatment), diet-treated diabetes mellitus or drug treated hypertension.
- Stable weight range of 4 kg or less the last 12 weeks,
- No major change in physical activity the last 12 weeks
You may not qualify if:
- Any symptomatic cardiovascular disease
- Diabetes requiring drug treatment
- Currently on special diet
- Hepatic/renal dysfunction
- Hypothyroidism (unstable)
- GI disorder impairing compliance with diet recommendation,
- History of unstable psychiatric or medical disorder,
- Need of lipid lowering drug,
- Alcohol or drug abuse,
- Participation in drug trial the last 30 days,
- Use of drugs for weight reduction last 12 weeks, pregnancy or planned pregnancy,
- Obesity of known endocrine origin, history of obesity surgery,
- Uncontrolled hypertension (\>160/100),
- Previous participation in \>3 weight reduction programs, or within last 12 months,
- Not willing to be randomized,
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ulleval University Hospital, dep. of preventive cardiology
Oslo, Oslo County, N-0407, Norway
Related Publications (2)
Klemsdal TO, Holme I, Nerland H, Pedersen TR, Tonstad S. Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome. Nutr Metab Cardiovasc Dis. 2010 Mar;20(3):195-201. doi: 10.1016/j.numecd.2009.03.010. Epub 2009 Jun 6.
PMID: 19502017RESULTHeggen E, Klemsdal TO, Haugen F, Holme I, Tonstad S. Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations. Metab Syndr Relat Disord. 2012 Dec;10(6):437-42. doi: 10.1089/met.2012.0012. Epub 2012 Aug 13.
PMID: 22889406DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tor Ole Klemsdal, MD, Ph.D
Ullevaal University Hospital, preventive medicine clinic
- STUDY CHAIR
Serena Tonstad, MD, Ph.D
Ullevaal University Hospital, preventive medicine clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 30, 2005
First Posted
October 3, 2005
Study Start
April 1, 2004
Primary Completion
June 1, 2006
Study Completion
November 1, 2006
Last Updated
July 1, 2011
Record last verified: 2004-02